about
Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor bindingMembrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of actionHIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected]In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection.A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41Increased functional stability and homogeneity of viral envelope spikes through directed evolution.Characterization of the steric defense of the HIV-1 gp41 N-trimer region.Structure based antibody-like peptidomimetics.HIV envelope: challenges and opportunities for development of entry inhibitors.Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 functionResidues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies.
P2860
Q28471980-F5E29F7A-DFBA-4073-808E-E87FF907E772Q28475682-5BE1775D-B484-424B-945A-4B94B02EF954Q28485218-57905699-80F9-4FD0-B8D6-5A16BED79E17Q33725718-C351D497-C9BC-4EE6-B2BD-3E8F16C12702Q33786216-1542CD2D-53D0-4BCB-A64B-74A9F06AC9B3Q33966639-C1EB7C51-89C6-4152-9553-7086DAD33D8DQ34611144-9A08D2FC-6B27-4E9E-BD8F-E52C539615F7Q36990646-1C41A95B-8BF3-46B7-BCD7-C9A8225E31E5Q37148681-E4EDC72A-B4FB-4F0F-89AB-0E1049ABDA84Q37850183-63507104-C13C-4331-8AFE-525C2176735BQ38076139-36D2900C-5219-4CA9-A46A-8D76D7564952Q38632078-7880EEFB-1ADA-4EC8-8119-E542297A87CDQ40399853-AFAB79B4-5879-4772-9E5B-62BBB1DC21DFQ43096886-A906D837-31A4-4F18-AC9B-102672298AE3
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Peptide mimic of the HIV envelope gp120-gp41 interface
@ast
Peptide mimic of the HIV envelope gp120-gp41 interface
@en
type
label
Peptide mimic of the HIV envelope gp120-gp41 interface
@ast
Peptide mimic of the HIV envelope gp120-gp41 interface
@en
prefLabel
Peptide mimic of the HIV envelope gp120-gp41 interface
@ast
Peptide mimic of the HIV envelope gp120-gp41 interface
@en
P2093
P2860
P1476
Peptide mimic of the HIV envelope gp120-gp41 interface
@en
P2093
Hong-Bo Pang
Michael S Kay
Sunghwan Kim
P2860
P304
P356
10.1016/J.JMB.2007.12.001
P407
P577
2007-12-07T00:00:00Z